InvestorsHub Logo
icon url

LuCo

11/10/14 10:47 AM

#27696 RE: KitchenRat #27693

And then it will shoot Right back down because it's just pre clinical trials. Thousands of biotechs make it through this stage, few make it to the market.

Nuvilex is already overpriced right now at 187 million. At 50 cents 375 million.

Really? Be prepared for more dilution coming with that s3 filing.